Identification of novel third-generation synthetic cannabinoids in products by ultra-performance liquid chromatography and time-of-flight mass spectrometry.
暂无分享,去创建一个
Kevin G Shanks | George S Behonick | Tim Dahn | Andrea Terrell | G. Behonick | Tim Dahn | Andrea R. Terrell | Kevin G. Shanks
[1] A. Lichtman,et al. Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation , 2009, The AAPS Journal.
[2] Y. Goda,et al. Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products , 2010, Forensic Toxicology.
[3] T. Sobolevsky,et al. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. , 2012, Drug testing and analysis.
[4] A. Duranti,et al. The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3′-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice , 2007, Journal of Pharmacology and Experimental Therapeutics.
[5] Ming-Jung Wu,et al. 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor. , 2003, Bioorganic & medicinal chemistry.
[6] P. Chandran,et al. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity. , 2010, Journal of medicinal chemistry.
[7] P. Chandran,et al. In vitro and in vivo characterization of A‐796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models , 2008, British journal of pharmacology.
[8] J. Ramsey,et al. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. , 2010, Journal of analytical toxicology.
[9] B. Logan,et al. Identification of Synthetic Cannabinoids in Herbal Incense Blends in the United States , 2012, Journal of forensic sciences.
[10] H. Schiebel,et al. Analysis of synthetic cannabinoids in “spice-like” herbal highs: snapshot of the German market in summer 2011 , 2012, Analytical and Bioanalytical Chemistry.
[11] Y. Goda,et al. URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products. , 2013, Forensic science international.
[12] Daniele Piomelli,et al. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). , 2006, CNS drug reviews.
[13] G. Behonick,et al. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry. , 2012, Journal of analytical toxicology.
[14] A. Duranti,et al. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues. , 2006, Pharmacological research.
[15] I. Mikhura,et al. UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products. , 2013, Drug testing and analysis.
[16] B. Cravatt,et al. Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes. , 2005, Chemistry & biology.
[17] D. Piomelli,et al. The Endogenous Cannabinoid Anandamide Produces δ-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport , 2007, Journal of Pharmacology and Experimental Therapeutics.
[18] G. Hynd,et al. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. , 2005, Bioorganic & medicinal chemistry.